287 related articles for article (PubMed ID: 20528079)
1. Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome.
Moon J; Chen M; Gandhy SU; Strawderman M; Levitsky DA; Maclean KN; Strupp BJ
Behav Neurosci; 2010 Jun; 124(3):346-61. PubMed ID: 20528079
[TBL] [Abstract][Full Text] [Related]
2. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
[TBL] [Abstract][Full Text] [Related]
3. Maternal choline supplementation in a mouse model of Down syndrome: Effects on attention and nucleus basalis/substantia innominata neuron morphology in adult offspring.
Powers BE; Kelley CM; Velazquez R; Ash JA; Strawderman MS; Alldred MJ; Ginsberg SD; Mufson EJ; Strupp BJ
Neuroscience; 2017 Jan; 340():501-514. PubMed ID: 27840230
[TBL] [Abstract][Full Text] [Related]
4. Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice.
Ash JA; Velazquez R; Kelley CM; Powers BE; Ginsberg SD; Mufson EJ; Strupp BJ
Neurobiol Dis; 2014 Oct; 70():32-42. PubMed ID: 24932939
[TBL] [Abstract][Full Text] [Related]
5. CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation.
Alldred MJ; Chao HM; Lee SH; Beilin J; Powers BE; Petkova E; Strupp BJ; Ginsberg SD
Hippocampus; 2018 Apr; 28(4):251-268. PubMed ID: 29394516
[TBL] [Abstract][Full Text] [Related]
6. Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice.
Kelley CM; Powers BE; Velazquez R; Ash JA; Ginsberg SD; Strupp BJ; Mufson EJ
J Comp Neurol; 2014 Apr; 522(6):1390-410. PubMed ID: 24178831
[TBL] [Abstract][Full Text] [Related]
7. Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.
Kelley CM; Ginsberg SD; Alldred MJ; Strupp BJ; Mufson EJ
Dev Neurobiol; 2019 Jul; 79(7):664-683. PubMed ID: 31120189
[TBL] [Abstract][Full Text] [Related]
8. Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
Gautier MK; Kelley CM; Lee SH; Alldred MJ; McDaid J; Mufson EJ; Stutzmann GE; Ginsberg SD
Neurobiol Dis; 2023 Nov; 188():106332. PubMed ID: 37890559
[TBL] [Abstract][Full Text] [Related]
9. Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.
Kelley CM; Ash JA; Powers BE; Velazquez R; Alldred MJ; Ikonomovic MD; Ginsberg SD; Strupp BJ; Mufson EJ
Curr Alzheimer Res; 2016; 13(1):84-96. PubMed ID: 26391045
[TBL] [Abstract][Full Text] [Related]
10. Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.
Strupp BJ; Powers BE; Velazquez R; Ash JA; Kelley CM; Alldred MJ; Strawderman M; Caudill MA; Mufson EJ; Ginsberg SD
Curr Alzheimer Res; 2016; 13(1):97-106. PubMed ID: 26391046
[TBL] [Abstract][Full Text] [Related]
11. Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult Ts65Dn trisomic mice.
Yan J; Ginsberg SD; Powers B; Alldred MJ; Saltzman A; Strupp BJ; Caudill MA
FASEB J; 2014 Oct; 28(10):4312-23. PubMed ID: 24963152
[TBL] [Abstract][Full Text] [Related]
12. Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome.
Powers BE; Velazquez R; Kelley CM; Ash JA; Strawderman MS; Alldred MJ; Ginsberg SD; Mufson EJ; Strupp BJ
Brain Struct Funct; 2016 Dec; 221(9):4337-4352. PubMed ID: 26719290
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
Alldred MJ; Chao HM; Lee SH; Beilin J; Powers BE; Petkova E; Strupp BJ; Ginsberg SD
FASEB J; 2019 Sep; 33(9):9871-9884. PubMed ID: 31180719
[TBL] [Abstract][Full Text] [Related]
14. Basal forebrain cholinergic neurons are vulnerable in a mouse model of Down syndrome and their molecular fingerprint is rescued by maternal choline supplementation.
Alldred MJ; Pidikiti H; Heguy A; Roussos P; Ginsberg SD
FASEB J; 2023 Jun; 37(6):e22944. PubMed ID: 37191946
[TBL] [Abstract][Full Text] [Related]
15. Maternal Choline Supplementation as a Potential Therapy for Down Syndrome: Assessment of Effects Throughout the Lifespan.
Powers BE; Velazquez R; Strawderman MS; Ginsberg SD; Mufson EJ; Strupp BJ
Front Aging Neurosci; 2021; 13():723046. PubMed ID: 34690739
[TBL] [Abstract][Full Text] [Related]
16. Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome.
Granholm AC; Ford KA; Hyde LA; Bimonte HA; Hunter CL; Nelson M; Albeck D; Sanders LA; Mufson EJ; Crnic LS
Physiol Behav; 2002 Nov; 77(2-3):371-85. PubMed ID: 12419414
[TBL] [Abstract][Full Text] [Related]
17. Dietary choline supplementation to dams during pregnancy and lactation mitigates the effects of in utero stress exposure on adult anxiety-related behaviors.
Schulz KM; Pearson JN; Gasparrini ME; Brooks KF; Drake-Frazier C; Zajkowski ME; Kreisler AD; Adams CE; Leonard S; Stevens KE
Behav Brain Res; 2014 Jul; 268():104-10. PubMed ID: 24675162
[TBL] [Abstract][Full Text] [Related]
18. Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer's Disease.
Alldred MJ; Penikalapati SC; Lee SH; Heguy A; Roussos P; Ginsberg SD
Mol Neurobiol; 2021 Oct; 58(10):5141-5162. PubMed ID: 34263425
[TBL] [Abstract][Full Text] [Related]
19. Maternal choline supplementation lessens the behavioral dysfunction produced by developmental manganese exposure in a rodent model of ADHD.
Howard SL; Beaudin SA; Strupp BJ; Smith DR
Neurotoxicol Teratol; 2024; 102():107337. PubMed ID: 38423398
[TBL] [Abstract][Full Text] [Related]
20. A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model.
Lockrow J; Boger H; Gerhardt G; Aston-Jones G; Bachman D; Granholm AC
J Alzheimers Dis; 2011; 23(3):471-89. PubMed ID: 21098982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]